Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Capital Leases: 2018-2024

Historic Capital Leases for Solid Biosciences (SLDB) over the last 5 years, with Sep 2024 value amounting to $307,000.

  • Solid Biosciences' Capital Leases fell 77.46% to $307,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $307,000, marking a year-over-year decrease of 77.46%. This contributed to the annual value of $1.2 million for FY2023, which is 27.54% down from last year.
  • As of Q3 2024, Solid Biosciences' Capital Leases stood at $307,000, which was down 67.79% from $953,000 recorded in Q2 2024.
  • Over the past 5 years, Solid Biosciences' Capital Leases peaked at $1.7 million during Q4 2022, and registered a low of $231,000 during Q1 2022.
  • Moreover, its 3-year median value for Capital Leases was $1.2 million (2023), whereas its average is $1.1 million.
  • Its Capital Leases has fluctuated over the past 5 years, first spiked by 590.91% in 2023, then tumbled by 77.46% in 2024.
  • Over the past 5 years, Solid Biosciences' Capital Leases (Quarterly) stood at $525,000 in 2020, then crashed by 44.19% to $293,000 in 2021, then soared by 481.23% to $1.7 million in 2022, then decreased by 27.54% to $1.2 million in 2023, then tumbled by 77.46% to $307,000 in 2024.
  • Its Capital Leases was $307,000 in Q3 2024, compared to $953,000 in Q2 2024 and $1.1 million in Q1 2024.